SOURCE: Amarin Corp. Plc

Amarin Corp. Plc

May 26, 2015 17:00 ET

Amarin to Present at the Jefferies 2015 Global Healthcare Conference

BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 26, 2015) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's President and Chief Executive Officer, is scheduled to present a general company update at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2, 2015, at 8:00 a.m. ET.

A live audio webcast of the presentation will be available at:

http://wsw.com/webcast/jeff88/amrn/

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to an ongoing cardiovascular outcomes study. Amarin's first product, Vascepa® (icosapent ethyl) capsules, is a highly pure EPA omega-3 prescription product. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

Contact Information